Data / Form D filings / Sustained Therapeutics Inc.
Sustained Therapeutics Inc.: Form D filings
Sustained Therapeutics Inc., a health care company in Vancouver, British Columbia, Canada, filed 3 Form D notices with the SEC in 2022. The latest, on September 26, 2022, reports $100,001 sold of a $100,001 offering to 1 investor.
Find out what Sustained Therapeutics Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10TH FLOOR, 595 HOWE STREET, Vancouver, British Columbia, Canada, V6C 2
- Phone
- (778) 388-3612
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Canada (Federal Level)
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1929737
The full lists. Form D filings in Other Health Care: 1,958 rows, $97.90, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 26, 2022 | Amendment | $100,001 | $100,001 | $0 | 1 | Aug 31, 2022 | sec.gov |
| Aug 25, 2022 | Amendment | $100,001 | $100,001 | $0 | 1 | May 20, 2022 | sec.gov |
| May 24, 2022 | New notice | $100,001 | $100,001 | $0 | 1 | May 2, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Martin Gleave | Executive Officer, Director | |
| Carol Ammon | Director | |
| Dennis Parolin | Director |
Every Form D from the week of Sep 26, 2022 · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Sustained Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.